HeyJaredJuliette Siegfried
- Indexed articles, last 90 days
- 4
- Latest publication
- Sep 16, 2026
- Outlet visibility, for Renal and Urology News
- Top 5M sites
- Earliest in this view
- Jul 29, 2026
Latest articles
Renal Function and Age Predict Mortality After Transplant in PBC (opens the original)
Read excerpt
Patients with primary biliary cholangitis (PBC) had the highest post-transplant mortality rate among 3 autoimmune liver disease (AILD) subtypes, according to findings published in Medicina. However, the retrospective cohort study found that the differences were not statistically significant. Researchers analyzed the outcomes of 94 patients who underwent liver transplantation for AILD: 26 with autoimmune hepatitis (AIH), 28 with PBC, and 40 with primary sclerosing cholangitis (PSC), at the Floren
Progressive CKD May Elevate Tryptase Levels, Causing Undue Suspicion for SM (opens the original)
Read excerpt
Serum baseline tryptase (sBT) levels can rise significantly as chronic kidney disease (CKD) advances, a finding investigators say should prompt caution before performing an extensive workup for systemic mastocytosis (SM) or hereditary alpha tryptasemia (HAT) in patients with declining kidney function, according to findings published in the Journal of Allergy and Clinical Immunology: Global. Results of a retrospective study from the Mayo Clinic Enterprise found median sBT levels increased with CK
Persistent Hematuria Linked to Higher ESKD Risk in Patients With FSGS (opens the original)
Read excerpt
Adults with focal segmental glomerulosclerosis (FSGS) who have persistent microscopic hematuria are significantly more likely to progress to end-stage kidney disease (ESKD) than those without it, according to findings published in Nephrology. Results of a retrospective cohort study showed that 60% of patients with persistent hematuria progressed to ESKD, compared with 32% of those without it. Researchers followed 236 adults with biopsy-proven primary podocytopathies, including 46 with FSGS, 114
A Case of Cyclosporine and Mycophenolate Reversing Drug-Resistant NOS-FSGS (opens the original)
Read excerpt
A 26-year-old woman with treatment-resistant focal segmental glomerulosclerosis (FSGS) achieved sustained remission on a combination of cyclosporine A (CsA) and mycophenolate mofetil (MMF) after failing corticosteroids and CsA monotherapy, according to a case report published in the Open Journal of Nephrology. The patient presented with 4 months of progressive lower-limb edema, severe nephrotic syndrome (proteinuria more than 9 g/day, serum albumin below 16 g/L), hypertension, and hematuria. An
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Renal and Urology News, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.